iNtRON Biotechnology, Inc. (KOSDAQ: 048530)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,740.00
+110.00 (1.95%)
Sep 12, 2024, 9:42 AM KST
-37.61%
Market Cap 186.87B
Revenue (ttm) 9.08B
Net Income (ttm) -6.09B
Shares Out 33.19M
EPS (ttm) -181.97
PE Ratio n/a
Forward PE n/a
Dividend 100.00 (1.76%)
Ex-Dividend Date n/a
Volume 9,139
Open 5,670.00
Previous Close 5,630.00
Day's Range 5,670.00 - 5,790.00
52-Week Range 5,250.00 - 10,380.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 12, 2024

About iNtRON Biotechnology

iNtRON Biotechnology, Inc. engages in the development of novel drugs in South Korea. It develops bacteriophage and endolysin based drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Employees 70
Stock Exchange KOSDAQ
Ticker Symbol 048530
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.